KK
NRIX icon

KLP Kapitalforvaltning’s Nurix Therapeutics NRIX Stock Holding History

KLP Kapitalforvaltning’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Hold
16,200
– – ﹤0.01% 1618
2026
Q1 		$251K Hold
16,200
– – ﹤0.01% 1730
2025
Q4 		$307K Buy
16,200
+800
+5% +$11.5K ﹤0.01% 1672
2025
Q3 		$142K Hold
15,400
– – ﹤0.01% 1948
2025
Q2 		$175K Buy
15,400
+4,300
+39% +$46.5K ﹤0.01% 1838
2025
Q1 		$132K Hold
11,100
– – ﹤0.01% 1917
2024
Q4 		$209K Buy
+11,100
New +$254K ﹤0.01% 1803

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KLP Kapitalforvaltning's NRIX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Nurix Therapeutics (NRIX) position steady in Q2 2026 at 16,200 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1618.

KLP Kapitalforvaltning first reported a position in NRIX in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • KLP Kapitalforvaltning held 16,200 shares of Nurix Therapeutics worth $393K as of Q2 2026.
  • KLP Kapitalforvaltning left its Nurix Therapeutics share count unchanged in Q2 2026.
  • Nurix Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1618 holding.
  • KLP Kapitalforvaltning first reported a position in Nurix Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.